RPA2 and colorectal carcinoma: More recently, polymorphisms in the miRNA-binding sites RPA2 and general transcription factor IIH subunit 1 (GTF2H1) mRNAs, both of which are involved in the NER pathway, have also been shown to correlate with CRC risk [6].